Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The MBL2 'LYQA secretor' haplotype is an independent predictor of postoperative myocardial infarction in whites undergoing coronary artery bypass graft surgery.

Circulation - 11 Sept 2007

Collard Charles D, Shernan Stanton K, Fox Amanda A, Bernig Toralf, Chanock Stephen J, Vaughn William K, Takahashi Kazue, Ezekowitz Alan B, Jarolim Petr, Body Simon C

Abstract excerpt

BACKGROUND: Mannose-binding lectin (MBL) is an important component of innate immunity and activator of the lectin complement pathway. Within the MBL2 gene are seven 5' "secretor" haplotypes that code for altered serum MBL levels and complement activation. However, recent evidence suggests that 3'...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Coronary Artery Bypass
Share to Haplotypes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Longitudinal Studies

Share to Mannose-Binding Lectin

Share to Myocardial Infarction

Share to Postoperative Complications

Share to Predictive Value of Tests

Share to White People

Source

Open in PubMed Open full text

Identifiers

PMID: 17846289
DOI: 10.1161/CIRCULATIONAHA.106.679530
PMCID: PMC3000829

Genes

MBL2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17846289-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The MBL2 'LYQA secretor' haplotype is an independent predictor of postoperative myocardial infarction in whites undergoing coronary artery bypass graft surgery.PMID 17846289Read ↗

Mannose-binding lectin deficiency is associated with myocardial infarction: the HUNT2 study in Norway.Semantic proximity Read ↗

Prospective analysis of mannose-binding lectin genotypes and coronary artery disease in American Indians: the Strong Heart Study.Semantic proximity Read ↗

Inflammatory gene polymorphisms and risk of postoperative myocardial infarction after cardiac surgery.Semantic proximity Read ↗

Heterozygosity of mannose-binding lectin (MBL2) genotypes predicts advantage (heterosis) in relation to fatal outcome in intensive care patientsSemantic proximity Read ↗

Mannose binding lectin 2 haplotypes do not affect the progression of coronary atherosclerosis in men with proven coronary artery disease treated with pravastatin.Semantic proximity Read ↗

Genetic and other factors determining mannose-binding lectin levels in American Indians: the Strong Heart Study.Semantic proximity Read ↗

Mannose-binding lectin genotype and phenotype in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.Semantic proximity Read ↗

Lung cancer survival and functional polymorphisms in MBL2, an innate-immunity gene.Semantic proximity Read ↗

Low Mannose-Binding Lectin (MBL) genotype is associated with future cardiovascular events in type 2 diabetic South Asians. A prospective cohort study.Semantic proximity Read ↗

Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation.Semantic proximity Read ↗

Functional mannose-binding lectin haplotype variants are associated with Alzheimer's disease.Semantic proximity Read ↗

Genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human stroke.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.